Non-steroidal anti-oestrogens inhibit the differentiation of synovial macrophages into dendritic cells

被引:32
作者
Komi, J
Möttönen, M
Luukkainen, R
Lassila, O
机构
[1] Turku Univ, Dept Med Microbiol, Turku Immunol Ctr, Turku 20520, Finland
[2] Turku Univ, Turku GRad Sch Biomed Sci, Turku 20520, Finland
[3] Satalinna Hosp, Dept Rheumatol, Harjavalta, Finland
基金
芬兰科学院;
关键词
toremifene; tamoxifen; rheumatoid arthritis; dendritic cells;
D O I
10.1093/rheumatology/40.2.185
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Dendritic cells (DC) have been suggested to play an important role in the pathogenesis of rheumatoid arthritis (RA). Agents that inhibit DC differentiation and function may have a therapeutic value in the treatment of RA. Objective. To examine the effect of the non-steroidal anti-oestrogens toremifene and tamoxifen on the differentiation of synovial fluid (SF) macrophages into DC. Methods. SF macrophages from patients with RA were cultured with interleukin (IL)-4 and granulocyte/macrophage colony-stimulating factor (GM-CSF) in the presence or absence of anti-oestrogens. The expression of cell surface markers on SF antigen-presenting cells (APC) was studied by flow cytometry. The capacity of SF APC to stimulate allogeneic T cells was studied using the mixed lymphocyte reaction. The production of tumour necrosis factor-alpha, IL-10 and transforming growth factor-beta1 was studied using ELISA. Results. Anti-oestrogens inhibited the differentiation of SF macrophages into DC and the capacity of SF macrophage-derived DC to stimulate allogeneic T cells. Conclusions. By inhibiting the differentiation of SF macrophages into DC, non-steroidal anti-oestrogens may have beneficial effects in RA.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 53 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]   MONITORING THE CHEMOSENSITIZING EFFECTS OF TOREMIFENE WITH FLOW-CYTOMETRY IN ESTROGEN-RECEPTOR NEGATIVE MULTIDRUG RESISTANT HUMAN BREAST-CANCER CELLS [J].
BAKER, WJ ;
WIEBE, VJ ;
KOESTER, SK ;
EMSHOFF, VD ;
MAENPAA, JU ;
WURZ, GT ;
DEGREGORIO, MW .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 24 (01) :43-49
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[5]   Tamoxifen-induced remission of psoriasis [J].
Boyd, AS ;
King, LE .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 41 (05) :887-889
[6]   Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10 [J].
Buelens, C ;
Verhasselt, V ;
DeGroote, D ;
Thielemans, K ;
Goldman, M ;
Willems, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (08) :1848-1852
[7]  
BUTTA A, 1992, CANCER RES, V52, P4261
[8]   ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING [J].
CAUX, C ;
MASSACRIER, C ;
VANBERVLIET, B ;
DUBOIS, B ;
VANKOOTEN, C ;
DURAND, I ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1263-1272
[9]   Origin, maturation and antigen presenting function of dendritic cells [J].
Cella, M ;
Sallusto, F ;
Lanzavecchia, A .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :10-16
[10]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752